Imago BioSciences, Inc. - Common stock (NQ:IMGO)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 10, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Imago BioSciences, Inc. - Common stock

< Previous 1 2 Next >

7 Healthcare Stocks That Will Be Big Winners in 2023 ↗

January 31, 2023

Healthcare stocks had a strong 2022 which will continue throughout 2023 making these picks ones to consider.

Via InvestorPlace

5 Top Pharma Stocks of 2022 to Buy for the Long Haul ↗

January 06, 2023

The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks.

Via InvestorPlace

Looking Into Imago BioSciences's Recent Short Interest ↗

January 04, 2023

Imago BioSciences's (NASDAQ:IMGO) short percent of float has risen 41.79% since its last report. The company recently reported that it has 1.00 million shares sold short, which is 3.97% of all regular...

Via Benzinga

5 Most Expensive Health Care Stocks You Should Worry About ↗

January 03, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

How Is The Market Feeling About Imago BioSciences? ↗

December 09, 2022

Imago BioSciences's (NASDAQ:IMGO) short percent of float has fallen 3.48% since its last report. The company recently reported that it has 3.43 million shares sold short, which is 13.61% of all regular...

Via Benzinga

Analyst Ratings for Imago BioSciences ↗

November 28, 2022

Via Benzinga

What 5 Analyst Ratings Have To Say About Imago BioSciences ↗

November 22, 2022

Via Benzinga

Expert Ratings for Imago BioSciences ↗

November 22, 2022

Via Benzinga

3 Dow Stocks to Take Seriously in 2023 ↗

November 29, 2022

The top Dow stocks for 2023 are all big free cash flow generators that ought to be able to cope with whatever next year brings.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022 ↗

November 28, 2022

Via Benzinga

Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday ↗

November 22, 2022

Via Benzinga

Nasdaq Down More Than 100 Points; Gold Falls 1% ↗

November 21, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Monday.

Via Benzinga

Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday ↗

November 22, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session ↗

November 21, 2022

Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 21, 2022

During Monday's session, 50 stocks hit new 52-week highs.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 21, 2022

Via Benzinga

OPEC Rumors, Energy Stocks Drag Wall Street ↗

November 21, 2022

The Dow Jones Industrial Average and Nasdaq Composite are both down over 90 points midday, while the S&P 500 Index sits comfortably below fair value as well.

Via Talk Markets

Crude Oil Down Over 5%; Imago BioSciences Shares Spike Higher ↗

November 21, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping over 100 points on Monday.

Via Benzinga

Imago BioSciences, GrafTech International And Some Other Big Stocks Moving Higher On Monday ↗

November 21, 2022

U.S. stocks traded lower, with the Dow Jones dropping around 70 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

As Tesla Sinks to 2-Year Lows, This Nasdaq Stock Just Doubled ↗

November 21, 2022

Markets sent mixed messages to start out Thanksgiving week.

Via The Motley Fool

Why Is Imago Biosciences (IMGO) Stock Up 105% Today? ↗

November 21, 2022

Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share.

Via InvestorPlace

Nasdaq Drops Over 50 Points; Bob Iger Returns To Walt Disney ↗

November 21, 2022

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping over 50 points on Monday.

Via Benzinga

Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout ↗

November 21, 2022

Seagen who? Merck is putting its cash to work buying a smaller biotech company.

Via Investor's Business Daily

Cancer-Focused Imago BioSciences Shares Soar After Merck Deal ↗

November 21, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 21, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022 ↗

October 28, 2022

Upgrades

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Imago BioSciences: Here's What You Need To Know ↗

August 16, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of Imago BioSciences (NASDAQ:IMGO) and lower its price target from $36.00 to $35.00. Shares of Imago BioSciences are trading down 2.8% over...

Via Benzinga

70 Biggest Movers From Friday ↗

May 02, 2022

Gainers GTY Technology Holdings Inc. (NASDAQ: GTYH) shares climbed 115.2% to close at $6.09 as the company agreed to be acquired by GI Partners. Vaxxinity, Inc. (NASDAQ: VAXX)...

Via Benzinga

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022 ↗

February 14, 2022

Upgrades According to Mizuho, the prior rating for Murphy Oil Corp (NYSE:MUR) was changed from Neutral to Buy. In the fourth quarter, Murphy Oil showed an EPS of $0.40,...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.